Nano/Microfluidics for diagnosis of infectious diseases in developing countries.
Nano/Microfluidic technologies are emerging as powerful enabling tools for diagnosis and monitoring of infectious diseases in both developed and developing countries. Miniaturized nano/microfluidic platforms that precisely manipulate small fluid volumes can be used to enable medical diagnosis in a more rapid and accurate manner. In particular, these nano/microfluidic diagnostic technologies are potentially applicable to global health applications, since they are disposable, inexpensive, portable, and easy-to-use for detection of infectious diseases. In this paper, we review recent advances in nano/microfluidic technologies for clinical point-of-care applications at resource-limited settings in developing countries.
Lee
Won Gu
WG
Center for Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA 02139, USA.
Kim
Yun-Gon
YG
Chung
Bong Geun
BG
Demirci
Utkan
U
Khademhosseini
Ali
A
D003906:Developing Countries; D005434:Flow Cytometry; D015658:HIV Infections / Q000175:diagnosis; D006801:Humans; D007118:Immunoassay; D007239:Infections / Q000175:diagnosis*; D008288:Malaria / Q000175:diagnosis; D008838:Microcomputers; D044085:Microfluidics / Q000639:trends*; D036103:Nanotechnology / Q000639:trends*; D014376:Tuberculosis / Q000175:diagnosis